by van Rijswijk, Merlijn, Beirnaert, Charlie, Caron, Christophe, Cascante, Marta, Dominguez, Victoria, Dunn, Warwick B, Ebbels, Timothy M D, Giacomoni, Franck, Gonzalez-Beltran, Alejandra, Hankemeier, Thomas, Haug, Kenneth, Izquierdo-García, José L, Jimenez, Rafael C, Jourdan, Fabien, Kale, Namrata, Klapa, Maria I, Kohlbacher, Oliver, Koort, Kairi, Kultima, Kim, Le Corguillé, Gildas, Moreno, Pablo, Moschonas, Nicholas K, Neumann, Steffen, O’Donovan, Claire, Reczko, Martin, Rocca-Serra, Philippe, Rosato, Antonio, Salek, Reza M, Sansone, Susanna-Assunta, Satagopam, Venkata, Schober, Daniel, Shimmo, Ruth, Spicer, Rachel A, Spjuth, Ola, Thévenot, Etienne A, Viant, Mark R, Weber, Ralf J M, Willighagen, Egon L, Zanetti, Gianluigi and Steinbeck, Christoph
Abstract:
Metabolomics, the youngest of the major omics technologies, is supported by an active community of researchers and infrastructure developers across Europe. To coordinate and focus efforts around infrastructure building for metabolomics within Europe, a workshop on the “Future of metabolomics in ELIXIR” was organised at Frankfurt Airport in Germany. This one-day strategic workshop involved representatives of ELIXIR Nodes, members of the PhenoMeNal consortium developing an e-infrastructure that supports workflow-based metabolomics analysis pipelines, and experts from the international metabolomics community. The workshop establishedmetabolite identificationas the critical area, where a maximal impact of computational metabolomics and data management on other fields could be achieved. In particular, the existing four ELIXIR Use Cases, where the metabolomics community – both industry and academia – would benefit most, and which could be exhaustively mapped onto the current five ELIXIR Platforms were discussed. This opinion article is a call for support for a new ELIXIR metabolomics Use Case, which aligns with and complements the existing and planned ELIXIR Platforms and Use Cases.
Reference:
The future of metabolomics in ELIXIR. (van Rijswijk, Merlijn, Beirnaert, Charlie, Caron, Christophe, Cascante, Marta, Dominguez, Victoria, Dunn, Warwick B, Ebbels, Timothy M D, Giacomoni, Franck, Gonzalez-Beltran, Alejandra, Hankemeier, Thomas, Haug, Kenneth, Izquierdo-García, José L, Jimenez, Rafael C, Jourdan, Fabien, Kale, Namrata, Klapa, Maria I, Kohlbacher, Oliver, Koort, Kairi, Kultima, Kim, Le Corguillé, Gildas, Moreno, Pablo, Moschonas, Nicholas K, Neumann, Steffen, O’Donovan, Claire, Reczko, Martin, Rocca-Serra, Philippe, Rosato, Antonio, Salek, Reza M, Sansone, Susanna-Assunta, Satagopam, Venkata, Schober, Daniel, Shimmo, Ruth, Spicer, Rachel A, Spjuth, Ola, Thévenot, Etienne A, Viant, Mark R, Weber, Ralf J M, Willighagen, Egon L, Zanetti, Gianluigi and Steinbeck, Christoph), In F1000Research, volume 6, 2017.
Bibtex Entry:
@article{vanRijswijk:2017ega,
author = {van Rijswijk, Merlijn and Beirnaert, Charlie and Caron, Christophe and Cascante, Marta and Dominguez, Victoria and Dunn, Warwick B and Ebbels, Timothy M D and Giacomoni, Franck and Gonzalez-Beltran, Alejandra and Hankemeier, Thomas and Haug, Kenneth and Izquierdo-Garc{'i}a, Jos{'e} L and Jimenez, Rafael C and Jourdan, Fabien and Kale, Namrata and Klapa, Maria I and Kohlbacher, Oliver and Koort, Kairi and Kultima, Kim and Le Corguill{'e}, Gildas and Moreno, Pablo and Moschonas, Nicholas K and Neumann, Steffen and O'Donovan, Claire and Reczko, Martin and Rocca-Serra, Philippe and Rosato, Antonio and Salek, Reza M and Sansone, Susanna-Assunta and Satagopam, Venkata and Schober, Daniel and Shimmo, Ruth and Spicer, Rachel A and Spjuth, Ola and Th{'e}venot, Etienne A and Viant, Mark R and Weber, Ralf J M and Willighagen, Egon L and Zanetti, Gianluigi and Steinbeck, Christoph},
title = {{The future of metabolomics in ELIXIR.}},
journal = {F1000Research},
year = {2017},
volume = {6},
pages = {1649},
affiliation = {ELIXIR-NL, Dutch Techcentre for Life Sciences, Utrecht, 3503 RM, Netherlands.},
doi = {10.12688/f1000research.12342.2},
pmid = {29043062},
pmcid = {PMC5627583},
language = {English},
rating = {0},
date-added = {2018-03-16T12:38:52GMT},
date-modified = {2018-06-17T18:05:23GMT},
abstract = {Metabolomics, the youngest of the major omics technologies, is supported by an active community of researchers and infrastructure developers across Europe. To coordinate and focus efforts around infrastructure building for metabolomics within Europe, a workshop on the "Future of metabolomics in ELIXIR" was organised at Frankfurt Airport in Germany. This one-day strategic workshop involved representatives of ELIXIR Nodes, members of the PhenoMeNal consortium developing an e-infrastructure that supports workflow-based metabolomics analysis pipelines, and experts from the international metabolomics community. The workshop establishedmetabolite identificationas the critical area, where a maximal impact of computational metabolomics and data management on other fields could be achieved. In particular, the existing four ELIXIR Use Cases, where the metabolomics community - both industry and academia - would benefit most, and which could be exhaustively mapped onto the current five ELIXIR Platforms were discussed. This opinion article is a call for support for a new ELIXIR metabolomics Use Case, which aligns with and complements the existing and planned ELIXIR Platforms and Use Cases.},
url = {https://f1000research.com/articles/6-1649/v2},
local-url = {file://localhost/Users/jruizcabello/Documents/JRC/biblio/Papers-folder/Library.papers3/Files/7B/7BEF3EFD-5487-4136-B610-2FE4845FA0BA.pdf},
file = {{7BEF3EFD-5487-4136-B610-2FE4845FA0BA.pdf:/Users/jruizcabello/Documents/JRC/biblio/Papers-folder/Library.papers3/Files/7B/7BEF3EFD-5487-4136-B610-2FE4845FA0BA.pdf:application/pdf}},
uri = {url{papers3://publication/doi/10.12688/f1000research.12342.2}}
}